Rare condition

Primary acquired pure red cell aplasia

0

studies recruiting now

as of 7 Sept 2026

4

studies registered in total

as of 7 Sept 2026

0

countries with a recruiting site

as of 7 Sept 2026

None

recruiting study posted to date

among recruiting studies

Recruiting trials

No recruiting trial found right now.

4 studies are registered for Primary acquired pure red cell aplasia, but none was recruiting as of 7 Sept 2026. Here is what is still worth doing.

Keep watching

Get an email when a new Primary acquired pure red cell aplasia study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

About Primary acquired pure red cell aplasia

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Treatments being studied

7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Phase 3Cyclosporine (Capimune)
Phase 3Prednisolone (Cortalone)
Phase 3Mycophenolate Mofetil (Arzip)
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 2Isatuximab (Sarclisa)
Phase 2Dexamethasone (Aeroseb-dex)
Phase 2Linperlisib

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).